Swiprosin-1 is expressed in mast cells and up-regulated through the protein kinase CβI/η pathway
✍ Scribed by Ramesh P. Thylur; Young-Dae Kim; Min-Sung Kwon; Hyun-Mee Oh; Ho-Keun Kwon; Sang-Hyun Kim; Sin-Hyeog Im; Jang-Soo Chun; Zee-Yong Park; Chang-Duk Jun
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 423 KB
- Volume
- 108
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Swiprosin‐1 exhibits the highest expression in CD8^+^ T cells and immature B cells and has been thought to play a role in lymphocyte physiology. Here we report that swiprosin‐1 is also expressed in mast cells and up‐regulated in both in vitro cultured mast cells by phorbol ester and in vivo model tissues of passive cutaneous anaphylaxis and atopic dermatitis. Targeted inhibition of the specific protein kinase C (PKC) isotypes by siRNA revealed that PKC‐βI/η are involved in the expression of swiprosin‐1 in the human mast cell line HMC‐1. In contrast, down‐regulation of swiprosin‐1 by A23187 or ionomycin suggests that calcium‐signaling plays a negative role. The ectopic expression of swiprosin‐1 augmented PMA/A23187‐induced NF‐κB promoter activity, and resulted in increased expression of cytokines. Moreover, knock‐down of swiprosin‐1 attenuated PMA/A23187‐induced cytokine expression. Collectively, these results suggest that swiprosin‐1 is a PKC‐βI/η‐inducible gene and it modulates mast cell activation through NF‐κB‐dependent pathway. J. Cell. Biochem. 108: 705–715, 2009. © 2009 Wiley‐Liss, Inc.